Answers are grounded in this paper and cite their sources.
Esophageal cancers are highly lethal neoplasms which are generally refractory to conventional multidisciplinary interventions. Recent elucidation of the mechanisms of esophageal carcinogenesis, as well as preclinical studies utilizing chromatin remodeling agents and inhibitors of oncogene signaling in conjunction with conventional chemotherapeutic agents provide new opportunities for the development of potentially efficacious molecular targeted therapies for these malignancies.
No takes yet. Share an insight, caveat, or question.
Schrump et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: